Zain Khalpey/LinkedIn
Dec 19, 2025, 09:24
Zain Khalpey on A New Study Linking Low-dose Aspirin to Reduced Cancer Spread
Zain Khalpey, Adjunct Assistant Professor of Surgery at Columbia University Irving Medical Center, shared on LinkedIn:
”A paper in The New England Journal of Medicine outlines a mechanism by which low-dose aspirin may reduce cancer spread, particularly in colorectal cancer and in individuals with certain mutations or CHIP.
By lowering platelet activation and thromboxane A2 signaling, aspirin helps release T cells from immune suppression and supports antimetastatic immunity.
Follow Zain Khalpey for more on Ai and Healthcare.”
Read the full article in NEJM.
Article: Understanding How Aspirin Prevents Metastasis
Authors: Ruth E. Langley, John Burn
Stay updated on all scientific advances with Hemostasis Today.
-
Aug 31, 2026, 17:11Chokri Ben Lamine: Early Recognition and Immediate Treatment of Catastrophic APS
-
Aug 31, 2026, 17:06Nikolaos Ktenopoulos: COMPASS-ARTeCAT Trial Highlights Arterial Thrombosis in Patients With Cancer
-
Aug 31, 2026, 17:01Mark Kaplan: Same LDL-C, Different Coagulation, Different Outcomes, in FH
-
Aug 31, 2026, 16:55Kemal Karaagac: Milvexian Did Not Reduce Ischemic Events but Did Not Increase Fatal Bleeding
-
Aug 31, 2026, 16:47Improving Outcomes in AF-Related Stroke Beyond Anticoagulation at ESC 2026 – ESO
-
Aug 31, 2026, 16:39Shariq Shamim: Are We Going to Start DOAC post TAVI not DAPT?
-
Aug 31, 2026, 16:30Bartosz Hudzik: 5th Universal MI Definition Moves Closer to Biology in Women
-
Aug 31, 2026, 16:13Seema Dawood: Nucleated Red Blood Cells – What They Tell Us on a Peripheral Smear
-
Aug 31, 2026, 16:02Antonio Sorropago: Major Updates in Structural Heart Interventions